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Zebrafish (Danio rerio) have a number of strengths as a host model for infection,  2 
including genetic tractability, a vertebrate immune system similar to mammals, ease and  3 
scale of laboratory handling allowing analysis with reasonable throughput, and  4 
transparency, which facilitates visualization of the infection. With these advantages in  5 
mind, we examined whether zebrafish could be used to study Pseudomonas aeruginosa  6 
pathogenesis and found that infection of zebrafish embryos with live P. aeruginosa  7 
(PA14 or PAO1) by microinjection results in embryonic death, unlike E. coli or heat- 8 
killed P. aeruginosa, which have no effect. Similar to studies in mice, P. aeruginosa  9 
mutants deficient in type three secretion (pscD) or quorum sensing (lasR and mvfR) are  10 
attenuated in zebrafish embryos infected 50 hours post-fertilization (hpf), a  11 
developmental stage where both macrophages and neutrophils are present. In contrast,  12 
embryos infected 28 hpf, when only macrophages are initially present, succumb to lethal  13 
challenge with far fewer P. aeruginosa cells than embryos infected 50 hpf, are  14 
susceptible to infection with lasR and pscD deletion mutants, but are moderately resistant  15 
to infection with an mvfR mutant. Finally, we show that we can control the outcome of  16 
infection through the use of morpholinos, which allowed us to shift immune   17 
cell numbers, or small molecules (antibiotics), which rescue embryos from lethal  18 
challenge. Thus, zebrafish are a novel host model that is well suited for studying the  19 
interactions among individual pathogenic functions of P. aeruginosa, the role of  20 
individual components of host immune defense, and small molecule modulators of  21 
infection. 22 Clatworthy et al. 
  3 
Introduction  1 
Pseudomonas aeruginosa, one of the most common causes of nosocomial infections in  2 
the United States, typically infects injured, burned, and immunocompromised patients  3 
and is the primary cause of mortality among cystic fibrosis patients. It is a ubiquitous,  4 
Gram-negative bacterium adapted to a variety of niches including water, soil, and in  5 
association with other eukaryotic organisms. A number of evolutionarily divergent model  6 
hosts have been used to examine P. aeruginosa pathogenesis including amoebae, plants,  7 
nematodes, insects, and rodents (25, 36, 37). While much has been learned about P.  8 
aeruginosa pathogenesis from these models, each model has different strengths and  9 
weaknesses. Invertebrate model hosts such as Caenorhabditis elegans offer greater  10 
genetic tractability than rodent models. Moreover, the size and life cycle of organisms  11 
like C. elegans enable experiments such as comprehensive genetic screens that require  12 
large numbers of animals, in contrast to rodent models where such studies are often  13 
simply unfeasible due to cost and space requirements. The drawback to modeling human  14 
infections in invertebrate hosts is the dissimilarity between vertebrate and invertebrate  15 
immune responses. Invertebrate model hosts like Drosophila melanogaster and C.  16 
elegans do not possess adaptive immunity, a true complement system, or the immune cell  17 
multi-lineage complexity that is characteristic of humans, though D. melanogaster does  18 
possess phagocytic cells. Thus, a model host that combines the advantages of invertebrate  19 
and rodent models would be extremely powerful in efforts to further understand P.  20 
aeruginosa pathogenesis.  21 
Zebrafish (Danio rerio) have a number of advantages as a model host and thus  22 
have been used to study infections with a number of pathogens including Mycobacterium  23 Clatworthy et al. 
  4 
marinum, Salmonella typhimurium, Edwardsiella tarda, Staphylococcus aureus and  1 
Streptococcus iniae (12, 29, 34, 35, 52). Zebrafish are genetically tractable, both forward  2 
and reverse classical genetic approaches are possible in this organism (50) and  3 
sophisticated techniques using morpholinos and small molecules to precisely control  4 
spatiotemporal gene regulation in zebrafish have recently been developed (14, 44). In  5 
addition, chemical genetic approaches are feasible; chemical screens for small molecules  6 
that modulate a number of phenotypes including cell cycle progression and nervous and  7 
cardiovascular system development have been successfully performed in zebrafish (33,  8 
47). The capacity to conduct large-scale classical and chemical genetic studies in  9 
zebrafish is possible due to their fecundity and small size; embryos/larvae may be kept in  10 
96-well format during the first 5-6 days of development and a single adult pair of fish can  11 
generate ~200 embryos from a single mating. Furthermore, zebrafish embryos are  12 
optically transparent, which facilitates the visualization of development or infection  13 
progression in real-time. Finally, zebrafish are jawed vertebrates and thus possess both  14 
innate and adaptive immunity similar to mammals.    15 
Zebrafish immunity resembles mammalian immunity in a number of ways,  16 
including the expression of Toll-like receptors, complement proteins, pro-inflammatory  17 
cytokines, and acute phase response proteins (5, 10, 23, 26). On a cellular level, zebrafish  18 
innate immunity includes a myeloid compartment comprised of both  19 
monocyte/macrophage and granulocytic lineages (3). Primitive macrophages have been  20 
shown to be capable of engulfing invading microorganisms when inoculated 28-30 hours  21 
post fertilization (hpf) (17, 52), while primitive neutrophil differentiation lags slightly  22 
behind with functional neutrophils appearing by 32-48 hpf (22, 34). In contrast, while T  23 Clatworthy et al. 
  5 
cell progenitors do begin to populate the thymus by 3 dpf (days post-fertilization),  1 
functional maturity of lymphoid cells of the adaptive immune response has not been  2 
noted prior to 4-6 weeks post fertilization (50).  3 
P. aeruginosa utilizes a number of different virulence mechanisms to combat host  4 
defense including a type three secretion system (T3SS) and the production of multiple  5 
exotoxins including elastase, exotoxin A, and phopholipase C (8, 54). A number of  6 
evolutionarily divergent host species, including Dictyostelium discoideum, Arabidopsis  7 
thaliana, C. elegans, D. melanogaster, Galleria mellonella, and rodents have been used  8 
to identify and define the role of these virulence determinants in P. aeruginosa  9 
pathogenesis (15, 25, 27, 36, 37). Remarkably, these studies have demonstrated that a  10 
number of virulence determinants are required for infection across these evolutionarily  11 
divergent host species. For example, MvfR, a transcriptional regulator of quorum sensing  12 
and virulence, was originally isolated and characterized using lettuce leaf and  13 
Arabidopsis thaliana host models (9, 38), but is also required in  C. elegans and mouse  14 
burn models of P. aeruginosa infection (38, 48). Likewise, the quorum-sensing  15 
transcriptional regulator LasR, involved in the expression of virulence factors including  16 
elastase, phospholipase C, and exotoxin A, is required for full virulence in both murine  17 
(32, 42) and C. elegans (49) models. In contrast, T3S plays an important role in rodent  18 
and insect models (18, 27, 46), but not in A. thaliana and C. elegans host models (27).  19 
Thus, a model host that recapitulates the features of the mammalian (and ideally human)  20 
response to P. aeruginosa infection yet possesses advantages offered by invertebrate  21 
models would be invaluable.  22 Clatworthy et al. 
  6 
Given the similarities between the zebrafish and mammalian immune response  1 
and the advantages offered by zebrafish as a model organism, we investigated whether  2 
we could establish a P. aeruginosa infection model in zebrafish embryos. Here we  3 
demonstrate that introduction of P. aeruginosa into the circulation of zebrafish embryos  4 
establishes a lethal infection that requires quorum sensing and T3S for full virulence in  5 
later stage embryos. We find that ciprofloxacin and imipenem can rescue embryos from  6 
lethal challenge. Finally we examine the contribution of both host and pathogen  7 
determinants important for the progression to lethality and place these observations in the  8 
context of other P. aeruginosa infection models.  9 Clatworthy et al. 
  7 
Materials and Methods  1 
Infection conditions  2 
Zebrafish embryos derived from adults of the AB line were kept at 29˚C and staged 28  3 
hpf (or 50 hpf) according to previously described developmental criteria (19). Embryos  4 
were dechorionated manually or with pronase and then anesthetized with 0.015% ethyl 3- 5 
aminobenzoate methanesulfonate prior to injection. Bacterial cells (in a volume of 1 or 2  6 
nL) were microinjected into the yolk circulation valley, as visually ascertained under the  7 
stereomicroscope. The inoculum size was determined by injecting an equal volume of  8 
bacterial cells into PBS in duplicate before and after injections for each needle and  9 
enumerating CFU on LB agar; the inoculum size stated throughout is the mean number of  10 
cells determined from these dilutions with the standard deviation on average ~15% of the  11 
inoculum size. Injected embryos were returned to embryo medium (E3) (30), incubated at  12 
29ºC, and monitored for survival at regular intervals under a stereomicroscope. Very  13 
small numbers of bacteria (<140 cells/ mL), that had likely leaked from the micropipette  14 
during injection and been transferred along with the embryo, were determined to be  15 
present in the E3 media during monitoring. The scoring of living from dead embryos was  16 
ascertained by the presence of a heartbeat and circulating blood under a  17 
stereomicroscope. For antibiotic experiments, embryos were placed directly into E3 with  18 
or without ciprofloxacin and/or imipenem following infection by microinjection. All  19 
zebrafish experiments were performed with the approval of Massachusetts General  20 
Hospital’s Institutional Animal Care and Use Committee.  21 
  22 
Imaging infection  23 Clatworthy et al. 
  8 
Microscopy was performed with either a Zeiss SteREO Discovery.V12 stereomicroscope  1 
(Fig. 2) or a Zeiss Axio Imager.Z1 microscope equipped with differential interference  2 
contrast (DIC) and fluorescence optics using a 100X Plan-Apochromat oil immersion  3 
objective (N.A= 1.4). Living embryos were anesthetized in E3 media as described above  4 
prior to image acquisition using the stereomicroscope. Living embryos imaged using the  5 
Axio ImagerZ.1 were anesthetized as described above and mounted on glass depression  6 
slides in 1% low-melting agarose. Myeloperoxidase activity was detected using  7 
fluorescent tyramide (Cy3-TSA amplification reagent, Perkin Elmer, Waltham, MA) as a  8 
substrate for endogenous peroxidase activity as previously described (34) in embryos that  9 
had been fixed in 4% paraformaldehyde overnight at 4°C prior to staining. All images  10 
were collected using Axiovision (release 4.5) software.  11 
  12 
Bacterial strains and growth conditions  13 
Bacterial cells for microinjection were grown by streaking glycerol stocks to LB/agar  14 
plates (+/- antibiotics), incubated overnight at 37˚C, and scraped into PBS the following  15 
day. The cell concentration was estimated by measuring the OD600 of the resulting  16 
suspension, which was then diluted to a stock concentration of either 1250, 2500, 3000,  17 
4000, or 5000 cells/nl. Cells were passed through a 30 gauge needle 12 times to reduce  18 
clumping before loading the cells into a micropipette. The PA14, PA14 lasR,  19 
PA14 pscD (27), and PA14/GFP strains were obtained from Frederick Ausubel  20 
(Massachusetts General Hospital). PA14/GFP carries gfp encoded on pSMC21 (11).  21 
PA14 lasR is a clean deletion of lasR that was complemented by transforming  22 
PA14 lasR with a plasmid expressing the lasR gene in pUCP19 (43). The pscD deletion  23 Clatworthy et al. 
  9 
was complemented by allelic exchange using plasmid pEX18pscD1 (27). The  1 
PA14 mvfR and mvfR complemented strains were obtained from Laurence Rahme  2 
(Massachusetts General Hospital, (9)), and PAO1 was obtained from Stephen Lory  3 
(Harvard Medical School).  4 
  5 
Bacterial enumeration from infected embryos  6 
Individual embryos were euthanized with ethyl 3-aminobenzoate methanesulfonate (0.4  7 
mg/mL), washed twice in E3, and disrupted in 0.5 mL E3 using a 1 mL dounce  8 
homogenizer (Wheaton, 0.0035" - 0.0055") for 2 minutes. Homogenizers were then  9 
rinsed with an additional 0.5 mL E3, which was also added to the homogenate. Samples  10 
were supplemented with 200  L PBS and 130  L 1% Triton X-100, vortexed for 1  11 
minute prior to bath sonication (Branson 1510) for 10 minutes, and then plated on LB  12 
medium supplemented with 15  g/mL irgasan.  13 
  14 
Zebrafish morphant generation  15 
The pu.1 and gata1 morpholino oligos, previously described (16, 40), were obtained,  16 
along with the Gene Tools Standard Control morpholino, from Genetools (Philomath,  17 
OR). Morpholinos were injected into the embryo at the 1-2 cell stage at the following  18 
concentrations: gata1, 0.2mM; pu.1, 0.4 mM; and Standard Control, 0.4 mM. Elimination  19 
and expansion of the myeloid lineage in Pu.1 and Gata1 morphants, respectively, was  20 
confirmed by in situ hybridization for L-plastin expression as previously described (16,  21 
40).   22 
  23 Clatworthy et al. 
  10 
SYBR-Green Real-time quantitative (q)RT-PCR analysis  1 
Embryos were infected with PA14, the lasR deletion mutant, heat-killed PA14, or DH5α  2 
cells or with PBS (sham-infected) and RNA was isolated from pools of 10 infected and  3 
PBS sham-infected, homogenized embryos in each condition at each time point using  4 
Trizol reagent (Invitrogen). The resulting RNA was used to template first strand cDNA  5 
synthesis reactions using oligo dT and Superscript III reverse transcriptase (both from  6 
Invitrogen) according to the manufacturer’s instructions. Primers were designed using  7 
Primer 3 (41). The sequences of the gene specific TNFα (GenBank Accession No:  8 
NM_212859) and IL-1β  (GenBank Accession No: AY340959) and control (EF1a;  9 
GenBank Accession No: L47669) primers for detection are as follows: TNFaF: 5’- 10 
TGCTTCACGCTCCATAAGACC-3’, TNFaR: 5’-CAAGCCACCTGAAGAAAAGG-3’,  11 
IL1bF: 5’-TGGACTTCGCAGCACAAAATG-3’, IL1bR: 5’- 12 
CGTTCACTTCACGCTCTTGGATG-3’, EF1aF: 5’-AGAAGGAAGCCGCTGAGATG- 13 
3’, EF1aR: 5’-TGTCCAGGGGCATCAATAAT-3’; one primer from each primer pair  14 
overlapped an exon-exon junction. qRT-PCR reactions were carried out in a total volume  15 
of 25  l with cDNA corresponding to 100 ng total RNA and 50 nM gene specific or  16 
control primers. Transcript abundance from each RNA preparation was assayed in  17 
triplicate using an ABI 7300 real-time PCR machine (Applied Biosystems). Resulting Ct  18 
values from qRT-PCR assays were analyzed by the relative standard curve method and  19 
normalized to ef1a expression. The fold change in TNFα and IL-1β transcript levels  20 
relative to PBS-sham infected embryos is the mean and SEM determined from at least  21 
three RNA preparations from each experimental condition that were each assayed in  22 
triplicate.   23 Clatworthy et al. 
  11 
  1 
Statistical Analysis  2 
Both survival curve and cytokine expression data were graphed and statistically analyzed  3 
using GraphPad Prism 4 software. Statistical differences in survival curves were analyzed  4 
using the logrank test. Statistically significant differences in TNFα and IL-1β expression  5 
between PA14 and either the lasR mutant, heat-killed-PA14 or DH5α infected embryos  6 
were determined from 3-5 biologic replicates by one-way ANOVA followed by  7 
Bonferroni’s multiple comparison test.  8 Clatworthy et al. 
  12 
Results  1 
Inoculation of embryos with P. aeruginosa is lethal  2 
In an effort to develop a P. aeruginosa infection model in a genetically tractable  3 
vertebrate model host, we investigated whether P. aeruginosa could lethally infect  4 
zebrafish embryos at 28 hpf, a developmental stage where primitive macrophages are  5 
present and able to engulf invading microorganisms post infection (17, 52). Initial  6 
experiments to infect zebrafish with P. aeruginosa by immersing dechorionated embryos  7 
in a suspension of P. aeruginosa strain PA14 failed. Lethality required high  8 
concentrations of PA14 (1 x 10
9 colony forming units/mL (CFU/mL)) and was  9 
independent of the viability of the bacterial cells (data not shown), suggesting that the  10 
toxicity observed was due to a heat-stable component of the bacteria rather than from an  11 
active infection. While lower concentrations of P. aeruginosa (10
4 CFU/ml) have been  12 
shown to colonize the intestinal tract of 3 day post fertilization zebrafish larvae under  13 
similar static immersion conditions (39), we found that this concentration had no effect  14 
on embryo viability.  15 
  We next explored introducing PA14 into the zebrafish embryo bloodstream by  16 
microinjection into the yolk circulation valley (Fig. 1A), an area where venous blood  17 
returning from the trunk and tail is not contained within a vessel but instead flows freely  18 
over the lateral sides of the yolk before returning to the heart. Microinjection at 28 hpf of  19 
at least 1700 PA14 bacterial cells resulted in the death of all infected embryos by ~48  20 
hours post infection (hpi) (Fig. 1B) while microinjection of equal or greater numbers of  21 
heat-killed PA14 or Escherichia coli strain DH5α resulted in complete survival of  22 
infected embryos (Fig. 1B). PA14 killing was dose dependent with microinjection of  23 Clatworthy et al. 
  13 
fewer than 1500 cells resulting in incomplete lethality (data not shown). Finally, we  1 
examined whether P. aeruginosa lethality was specific to the PA14 strain, given that  2 
differences in virulence among common P. aeruginosa laboratory strains have been  3 
observed among different model hosts (37, 48), and found that the PAO1 strain was  4 
equally virulent to embryos infected 28 hpf (data not shown).   5 
We next examined the ability of PA14 to cause a lethal infection in zebrafish  6 
embryos at a later developmental stage when both macrophages and neutrophils are  7 
present and functional (50 hpf). We found that, similar to 28 hpf embryos, microinjection  8 
of PA14 into 50 hpf embryos also elicits a lethal phenotype. However, a higher bacterial  9 
dose (>4500 CFU) was required to achieve 100% lethality in embryos infected at 50 hpf  10 
(Fig. 1C), suggesting embryos 50 hpf are more immunocompetent than 28 hpf embryos  11 
and can mount a more robust host defense.   12 
  13 
Expansion of the bacterial cell population   14 
Zebrafish embryo transparency allowed us to monitor the progression of infection using  15 
PA14 cells expressing GFP (PA14/GFP) episomally from a strong constitutive promoter  16 
(pSMC21, (11)). In the hours immediately following inoculation, GFP fluorescence was  17 
undetectable from background autofluorescence throughout the length of the embryo  18 
under the magnification offered by a stereomicroscope (Fig. 2A). As infection  19 
progressed, the first detectable change observed was a slowing of the embryo circulation  20 
and heartbeat, followed by the appearance of GFP fluorescence. At later stages of  21 
infection, a few hours prior to death, increasing GFP fluorescence localized to either the  22 
area around the eye (Fig. 2B) or the heart and pericardial cavity, with more diffuse GFP  23 Clatworthy et al. 
  14 
fluorescence being detected along the length of the embryo until the time of death (Fig.  1 
2B). Embryo death was often preceded by what appeared to be necrotic cell death in the  2 
tail (Fig. 2C). Fluorescence persisted after death for several hours. No fluorescence  3 
(above background autofluorescence) was observed in embryos infected with heat-killed  4 
PA14/GFP (Fig. 2D).  5 
  To gain further insight into the dynamics of PA14 replication during infection of  6 
older zebrafish embryos, we examined the overall health, fluorescence pattern, and  7 
bacterial load over time in embryos infected at 50 hpf with PA14/GFP. Embryos were  8 
infected with PA14/GFP and monitored at 0, 2, 6, 10, 24, and 48 hpi for health and  9 
fluorescence. Eight embryos were sacrificed at each time point, homogenized, and plated  10 
to examine the bacterial expansion in embryos over time. The inoculum size determined  11 
from enumerating bacteria from 8 embryos sacrificed immediately following  12 
microinjection (10,600 CFU) was similar to the inoculum size determined by plating the  13 
injection volume directly from the micropipette (10,200 CFU).    14 
Similar to embryos infected 28 hpf, the appearance of fluorescence was only  15 
noted under a stereomicroscope several hours prior to death and was preceded by a  16 
slowing of the embryo heartbeat and a decrease in circulation in the embryo trunk and  17 
tail. In order to determine the correlation between the appearance of fluorescence and  18 
bacterial load in each embryo, bacteria were enumerated from 4 embryos displaying  19 
fluorescence (‘bright’) and 4 embryos that were not fluorescent (‘dim’), at 6 hpi and all  20 
subsequent time points; fluorescence was not observed prior to 6 hpi under a  21 
stereomicroscope. (Some living, ‘dim’ embryos were still present at 48 hpi, which is  22 
consistent with observed mild variations in time to death, with a mean of 48 hours.) In  23 Clatworthy et al. 
  15 
general, GFP fluorescence correlated with a higher bacterial load, with the highest  1 
bacterial loads observed reaching 3-4 x 10
5 cells within 24 hpi (Fig. 3). Conversely,  2 
embryos scored as ‘dim’ generally had a lower bacterial burden with a few exceptions.  3 
The overlapping bacterial burden among a few ‘bright’ and ‘dim’ embryos may have  4 
resulted from both the subjective nature of the analysis as well as the limited sensitivity  5 
of the stereomicroscope in comparing diffuse fluorescence across an entire organism and  6 
intense, localized, fluorescence.  In examining the correlation between bacterial burden  7 
and fluorescence, there was partial plasmid loss as the bacteria divide in the absence of  8 
selection within the embryo, despite the use of a GFP plasmid that is known to be  9 
retained relatively stably in the absence of selection in vitro (4).  This loss ranged from ~  10 
26% at 7 hpi to ~ 50% at 25 hpi.  However, this phenomenon is unlikely to have grossly  11 
affected the outcome of the experiment as the differences in bacterial load between  12 
fluorescent and non-fluorescent fish are on the log scale.  13 
Interestingly, the majority of embryos scored as ‘dim’ between 6-48 hpi displayed  14 
a decreased bacterial burden than in the original inoculum. There was variability in the  15 
bacterial burden among ‘dim’ embryos, with about half of them displaying an order of  16 
magnitude fewer bacterial cells than the initial inoculum size (Fig. 3). This finding  17 
suggests that at least some embryos have the ability to initially control infection and clear  18 
the majority of invading bacteria. At some point however, this immune control fails,  19 
resulting in bacterial expansion and eventually death.  20 
  21 
Quorum sensing and T3S are only required for full virulence in 50 hpf embryos  22 Clatworthy et al. 
  16 
To further characterize P. aeruginosa infection in zebrafish embryos in the context of  1 
other P. aeruginosa infection models, we analyzed whether P. aeruginosa mutants that  2 
are attenuated in other animal models are also attenuated in zebrafish embryos. We  3 
examined the ability of PA14 mutants containing in-frame, clean deletions of genes  4 
involved in quorum sensing (lasR), quorum sensing and the transcriptional regulation of  5 
pyocyanin and hydrogen cyanide production (mvfR), and in T3S (pscD) to kill embryos  6 
infected at 28 and 50 hpf. We found that the survival curves from embryos infected 28  7 
hpf with wildtype PA14 or either the isogenic lasR or pscD mutants were not statistically  8 
different from one another (Fig. 4A), indicating that the lasR and pscD mutants are not  9 
attenuated in embryos infected 28 hpf and that these genes are not required for full  10 
virulence at this early developmental stage. However, the survival curve from embryos  11 
infected with the mvfR mutant was statistically different from the curve generated from  12 
embryos infected with wildtype PA14 (p=0.01). Thus, the mvfR mutant is moderately  13 
attenuated in embryos infected 28 hpf.   14 
We then infected 50 hpf embryos with wild-type PA14 and the same panel of  15 
deletion mutants to determine whether P. aeruginosa’s full virulence arsenal would be  16 
required for infection at a later developmental stage, when embryos might be capable of  17 
mounting a more robust immune response.  In contrast to infection in earlier stage  18 
embryos, the lasR and pscD mutants were attenuated in the later stage embryos (Fig. 4B  19 
and D) and the level of attenuation with the mvfR mutant was even more pronounced than  20 
in embryos infected 28 hpf, with 60% survival in embryos infected 50 hpf (Fig. 4C)  21 
compared to 20% survival in embryos infected 28 hpf with the mvfR mutant (Fig. 4A).  22 
The survival curves for embryos infected at 50 hpf with the deletion mutants differed  23 Clatworthy et al. 
  17 
significantly from those infected with the wildtype PA14 strain (the logrank test between  1 
PA14 and each mutant was p<0.0001 in each pairwise comparison). All mutant  2 
phenotypes could be complemented by reintroduction of the respective, deleted gene  3 
(Fig. 4B-D) with the logrank test between each mutant strain and its corresponding  4 
complemented strain determined to be p<0.05 in each pairwise comparison.  Thus, while  5 
lasR-mediated quorum sensing and T3S are not required for full virulence in the infection  6 
of early-stage embryos, they are required for full virulence during infection of later-stage  7 
embryos. Likewise, the mvfR gene is also required for full virulence in later-stage  8 
embryos but it additionally contributes to some degree to virulence during infection of  9 
early-stage embryos. While mvfR and lasR are both involved in regulating quorum- 10 
sensing controlled genes, the genes they positively regulate only partially overlap (13)  11 
and mvfR has been reported to be a stronger determinant of virulence than lasR. Survival  12 
has been recorded to be slightly greater for mice infected with mvfR mutants than with  13 
the lasR mutant (9, 38, 49). Thus, it is not entirely surprising that there is a difference in  14 
phenotype between the lasR and mvfR mutant in embryos infected 28hpf even though  15 
they are both generally involved in the transcriptional regulation of genes involved in  16 
quorum sensing.  17 
  18 
The myeloid cell lineage affects susceptibility to lethal infection    19 
Since the susceptibility to infection with various PA14 mutant strains was dependent on  20 
embryo age and thus correlated with the development and function of the host immune  21 
defense, we sought to characterize the embryonic immune response to PA14 by  22 
examining the contribution of embryonic myeloid cells (macrophages and neutrophils) to  23 Clatworthy et al. 
  18 
defense against P. aeruginosa infection. Taking advantage of zebrafish embryo  1 
transparency, we were able to visually confirm that PA14/GFP bacteria were indeed  2 
engulfed by both myeloperoxidase positive-neutrophils and macrophages (Fig. 5).   3 
  We further examined the contribution of myeloid cells to defense against P.  4 
aeruginosa infection genetically, using morpholino knockdown of transcription factors  5 
that regulate myelo- and erythropoesis. In zebrafish embryos, primitive myeloid and  6 
erythroid cells arise from a common myeloid-erythroid progenitor (40), whose fate is  7 
determined by the transcription factors Pu.1 and Gata1, which negatively regulate  8 
erythroid or myeloid development, respectively (16, 40). Knockdown of Pu.1 shifts  9 
progenitor cells to an erythroid cell fate, thus eliminating myeloid cells from the  10 
developing embryo and increasing the number of erythroid cells present (40). Gata1  11 
inhibition antithetically commits progenitor cells to a myeloid cell fate, thereby  12 
effectively increasing the number of myeloid cells available to combat infection and  13 
eliminating erythroid cells (16, 40).   14 
  We first confirmed the elimination and expansion of the myeloid lineage in Pu.1  15 
and Gata1 morphants, respectively, by in situ hybridization for L-plastin expression (Fig.  16 
6A). We then found that Pu.1 morphants are exquisitely susceptible to infection with both  17 
wild-type PA14 and the pscD mutant in 50 hpf embryos, confirming that myeloid cells in  18 
the developing embryo are required to combat P. aeruginosa infection (Fig. 6B). We then  19 
determined whether susceptibility to infection with PA14 or the pscD mutant could be  20 
altered by increasing the number of myeloid cells by Gata1 knockdown. In later stage  21 
embryos (50 hpf), Gata-1 morphants were less susceptible to infection with PA14  22 
compared with control embryos (Fig. 6C; logrank test between control and Gata-1  23 Clatworthy et al. 
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morphants infected with PA14 was p=0.0002), suggesting that the additional numbers of  1 
myeloid cells (macrophages and neutrophils) present at this stage offered greater  2 
protection from the lethality of PA14. Interestingly, there was no difference in the  3 
survival of either control or Gata1 morphants infected with the pscD mutant, suggesting  4 
that there is a mode of death independent of the T3SS that cannot be rescued with greater  5 
numbers of myeloid lineage cells.  6 
  7 
Cytokine response to infection   8 
Since pro-inflammatory cytokine expression is an integral part of the vertebrate immune  9 
response to infection and a clear advantage of modeling P. aeruginosa infection in  10 
zebrafish rather than in invertebrate hosts, we examined zebrafish pro-inflammatory  11 
cytokine expression in response to PA14 infection. We quantified relative transcript  12 
levels of the pro-inflammatory cytokines TNFα and IL-1β by real-time RT-PCR in  13 
embryos that were infected either 28 or 50 hpf with either PA14, the lasR mutant, heat- 14 
killed PA14, or E. coli DH5α cells. Embryos that had been infected at 28 hpf  15 
demonstrated similar levels of induction of both TNFα and IL-1β at 4 hpi regardless of  16 
whether they were infected with PA14, the lasR mutant, heat-killed PA14, or DH5α cells  17 
(Fig. 7). By 18 hpi however, TNFα and IL-1β levels in embryos infected with heat-killed  18 
PA14 or DH5α cells had decreased or remained at similar levels compared with levels  19 
observed 4 hpi. In contrast, in embryos infected with live PA14, both TNFα and IL-1β  20 
transcript levels had increased significantly over levels observed 18 hpi in embryos  21 
infected with either heat-killed or DH5α cells (TNFα, p<0.01; IL-1β, p<0.05; overall  22 
data set: TNFα, p=0.0026 and IL-1β, p=0.0073) (Fig. 7).  23 Clatworthy et al. 
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The pro-inflammatory cytokine expression pattern observed in embryos infected  1 
50 hpf with PA14 was even more striking. While the induction of TNFα at 4 hpi in  2 
embryos infected with PA14 was not statistically different from the levels of induction  3 
observed with any other strain, the level of TNFα at 18 hpi in embryos infected with  4 
PA14 was statistically higher from levels observed from embryos infected with either  5 
heat-killed PA14 (p<0.01) or DH5α cells (p<0.05) (overall data set, p=0.0068) (Fig. 7A).  6 
Upregulation of IL1β expression was even more dramatic, with expression levels  7 
significantly greater both at 4 hpi (p<0.01; overall data set, p=0.0058) and 18 hpi  8 
(p<0.05; overall data set, p=0.0024) compared to levels in embryos infected with either  9 
DH5α or heat-killed PA14 (Fig. 7B).    10 
In addition to the difference in cytokine response to PA14 or heat-killed PA14/  11 
DH5α challenge, there was also an interesting difference in cytokine induction between  12 
wild-type PA14 and the lasR deletion mutant. While there was no statistically significant  13 
difference in either TNFα or IL-1β expression levels at either 4 or 18 hpi in embryos  14 
infected 28 hpf with either PA14 or the lasR mutant, there were notable differences in  15 
these cytokines in embryos infected 50 hpf. TNFα expression at 18 hpi in embryos  16 
infected 50 hpf with the lasR deletion mutant was significantly lower (p<0.05; overall  17 
data set, p=0.0068) than the level observed after infection with PA14 and more closely  18 
mirrored the expression levels observed following infection with either heat-killed PA14  19 
or DH5α cells (Fig. 7A). However, there was no statistically significant difference in  20 
IL1β expression between lasR deletion mutant or wildtype PA14-infected embryos  21 
inoculated 50 hpf (Fig. 7B). Thus, it would appear that levels of TNFα and not IL-1β  22 Clatworthy et al. 
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expression late in PA14 infection correlate with death, as the lasR mutant is attenuated in  1 
embryos infected 50 hpf.   2 
  3 
Small molecules are capable of rescuing embryos from lethal infection   4 
One advantage of using zebrafish embryos to model human disease is the ability to  5 
conduct chemical screens for small molecules that perturb a given phenotype in a whole  6 
organism model (24). With this in mind, we examined whether treatment of infected  7 
embryos with known anti-Pseudomonal antibiotics could rescue zebrafish embryos from  8 
the lethality of PA14 infection. We found that either ciprofloxacin (50  g/ml) or  9 
imipenem (50  g/ml) could rescue 65-75% of embryos from lethal P. aeruginosa  10 
infection when embryos were inoculated at 50 hpf (Fig. 8B). In contrast, embryos  11 
infected 28 hpf required a cocktail of both imipenem (200  g/ml) and ciprofloxacin (150  12 
 g/ml) to rescue similar embryo numbers (Fig. 8A). It is possible that either the increased  13 
immunocompetence of 50 hpf embryos and/ or potentially an increased ability to absorb  14 
antibiotics orally later in infection (as the zebrafish larval mouth opens and intestines  15 
become motile 72 hpf) accounts for the observation that lower concentrations of single  16 
antibiotic can rescue more embryos inoculated 50 hpf than embryos inoculated 28 hpf.  17 
Notably, the concentrations of antibiotic required for protection are much higher than the  18 
minimum inhibitory concentration (MIC) of either antibiotic for PA14 in axenic culture  19 
(ciprofloxacin, MIC= 0.8  g/ml; imipenem, MIC=1.6  g/ml), suggesting that  20 
pharmacokinetic and pharmacodynamic issues of antibiotic distribution in the host are  21 
dictating the required concentrations for rescue.   22 
  23 Clatworthy et al. 
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Discussion  1 
We report that P. aeruginosa can establish a lethal infection in zebrafish embryos, thus  2 
establishing a new host model for studying P. aeruginosa pathogenesis that combines  3 
genetic tractability and vertebrate immunity. The outcome of infection can be influenced  4 
on the pathogen side by both the inoculum size and the presence of known virulence  5 
determinants (lasR, mvfR, and pscD) and on the host side by developmental stage and the  6 
presence of immune cells. The outcome of infection can also be modulated by the  7 
addition of small molecules to the embryo media. Using this model, one can examine the  8 
complex host-pathogen relationship while manipulating the pathogen and/or the host  9 
using classical or chemical genetics.   10 
  Notably, we find that the host response to infection is dependent upon the  11 
developmental stage of the embryo. We find that more bacterial cells are required to  12 
achieve 100% lethality in embryos inoculated 50 hpf than in embryos inoculated 28 hpf.  13 
While 28 hpf embryos are slightly smaller (~2.5mm) in length than 50 hpf embryos  14 
(~3.1mm), the difference in body mass between 28 and 50 hpf embryos is relatively small  15 
and unlikely account for the difference in P. aeruginosa lethal dose between these two  16 
developmental stages. If the toxicity of P. aeruginosa at 28 and 50 hpf was solely related  17 
to body mass, one would expect the pattern of susceptibility to infection with the lasR,  18 
pscD, and mvfR mutant strains examined to be the same between 28 and 50 hpf embryos.  19 
Instead, we find that embryos inoculated 28 hpf are equally susceptible to infection with  20 
the either the wildtype PA14 strain or the lasR and pscD mutant strains unlike embryos  21 
inoculated 50 hpf. The difference in susceptibility to mutant strains suggests that P.  22 
aeruginosa requires its full-virulence arsenal in 50 hpf embryos in order to create a niche  23 Clatworthy et al. 
  23 
where is can survive and divide. In contrast, P. aeruginosa’s full virulence arsenal is not  1 
required to create a niche where it can survive and divide within 28 hpf embryos,  2 
suggesting that embryos 28 hpf are less immunocompetent than embryos 50 hpf to  3 
combat P. aeruginosa challenge.    4 
  The development of host immunity is a complex process that requires a series of  5 
coordinated events, including functional differentiation of immune cells, expansion of  6 
immune cell populations, and the expression of other immune functions such as  7 
complement proteins. Formally, any one or a combination of these possibilities may  8 
account for the difference in immunocompetence between 28 and 50 hpf embryos.  9 
Clearly, the presence of myeloid lineage cells is an important step for embryo survival  10 
following infection, as evidenced by the rapid death of Pu.1 morphants.  Moreover, the  11 
expansion of the myeloid population renders them less susceptible to infection as  12 
evidenced by the Gata1 morphants, suggesting that the decreased susceptibility of the  13 
later embryos could be due to an increase in myeloid cell numbers. However, the  14 
difference in phenotype between the two stages of embryos can also be accounted for by  15 
differences in functional maturity of the myeloid cells present as embryos infected 28 hpf  16 
initially do not have functional neutrophils. Clearly, a more detailed understanding of the  17 
timing and development of immunologic competence in zebrafish is required before one  18 
could attribute a given immunologic function to the difference in phenotype between  19 
these two different embryonic stages.   20 
  Both macrophages and neutrophils, that we observed to engulf P. aeruginosa, are  21 
likely to be important in combating P. aeruginosa infection in embryos, as they are in  22 
human infection. However, the individual contributions of each cell type in controlling P.  23 Clatworthy et al. 
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aeruginosa infection in zebrafish embryos cannot currently be determined genetically, as  1 
there is no known gene that one could specifically target that would disrupt either   2 
macrophage or neutrophil differentiation. While recent work suggests that zebrafish  3 
primitive macrophages are able to phagocytose microbes to a far greater extent than  4 
primitive neutrophils (20), the individual contribution of macrophages and neutrophils to  5 
defense against P. aeruginosa infection awaits further study.   6 
While embryos inoculated 50 hpf are more capable of successfully mounting a  7 
defense against infection with P. aeruginosa strains mutated in different virulence  8 
mechanisms, they still succumb to infection with wild-type PA14 even though pro- 9 
inflammatory cytokine expression both early and late in infection is robust.  It is possible  10 
that the consistently high levels of TNFα observed during PA14 infection may be  11 
detrimental to embryonic survival considering TNFα’s known effects on vascular  12 
permeability in mammals. Intraperitoneal injection of high doses of LPS alone in  13 
mammals are known to result in high levels of expression of TNFα that can result in  14 
dramatic increases in vascular permeability and death (51). While fish are thought to be  15 
more resistant to LPS toxicity than rodents or calves (2), zebrafish larvae are clearly  16 
sensitive to immersion in high concentrations of LPS and display pathophysiologic  17 
features characteristic of LPS intoxication similar to mammals (1). Here, the introduction  18 
of LPS in the form of either heat-killed PA14 or DH5α cells into the zebrafish embryo  19 
bloodstream does not result in high levels of TNFα transcripts at 18 hpi and is  20 
insufficient to result in lethality. Introduction of intact PA14 bacteria on the other hand  21 
does result in high levels of TNFα late in infection and this observation is correlated with  22 Clatworthy et al. 
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death. Whether high levels of TNFα induction in PA14-infection contribute to embryonic  1 
lethality or are simply a marker of PA14 infection awaits further study.   2 
  3 
Comparison to other models  4 
The virulence determinants required for infection in zebrafish embryos 50 hpf are more  5 
similar to those required in rodent models of acute P. aeruginosa infection (9, 18, 32, 42,  6 
46, 49), than to invertebrate models like C. elegans. The quorum sensing mutants lasR  7 
and mvfR are attenuated in zebrafish and the mouse burn model to approximately the  8 
same degree, with ~50% survival for lasR and mvfR mutants in both hosts (38, 49). Here  9 
we also find that deletion of pscD attenuates infection in 50 hpf embryos and thus, T3S is  10 
required for full virulence in zebrafish, similar to burn, neutropenic, and acute pneumonia  11 
murine infection models (18, 46, 53) and unlike infection in C. elegans, where pscD is  12 
fully dispensable for infection (27). Since intravenous inoculation of zebrafish embryos  13 
elicits an acute, bacteremic infection that most closely resembles the mouse burn model  14 
of P. aeruginosa infection, based on the levels of attenuation of the mutants examined,  15 
this model will perhaps be more useful in modeling the systemic P. aeruginosa infections  16 
that occur in burned and immunocompromised patients than in chronically infected  17 
patients where mutations in lasR and defects in T3S have been noted to appear during the  18 
course of persistent infection (21, 45).   19 
  20 
Advantageous features of a P. aeruginosa infection model in zebrafish  21 
One advantage of this model is the ease with which various pathogen components can be  22 
analyzed in the context of varying host components, such as examining different P.  23 Clatworthy et al. 
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aeruginosa mutants infected at different developmental stages or examining infection  1 
while altering immune cell numbers using morpholinos to shift myeloid and erythroid  2 
cell populations. Another advantage, unlike most model host organisms, is that zebrafish  3 
are amenable to chemical genetics as well as classical genetics (24). Here we find that the  4 
outcome of infection can also be modulated by the addition of small molecules to the  5 
embryo media, thus this model can also be used to probe P. aeruginosa pathogenesis in  6 
the intact host using chemical genetics. We show that forward chemical genetic screens  7 
are feasible in this infection model by rescuing infected embryos with small molecules  8 
added to the surrounding water. Lower concentrations of antibiotics are sufficient to  9 
rescue embryos infected at 50 hpf than at 28 hpf from death. While we do not know the  10 
mechanisms for attaining adequate tissue and bloodstream concentrations, passive  11 
diffusion of the antibiotics likely occurs and accounts for the success of other reported  12 
chemical genetic screens in zebrafish embryos (33, 47).   13 
  Chemical screening of whole-organism infection models is an attractive approach  14 
for identifying next-generation antimicrobials, particularly given the current climate  15 
where antibiotic resistance is outpacing antibiotic discovery and development. Our  16 
current antibiotic stockpile is largely composed of variations of compounds discovered  17 
~40-60 years ago for their ability to kill or inhibit the growth of logarithmically growing  18 
bacterial cells in vitro. Since that time, with the exceptions of the narrow spectrum drugs  19 
daptomycin and linezolid, no new classes of clinically relevant antibiotics have been  20 
discovered. More recent efforts using target-based approaches to identify inhibitors of  21 
gene products thought to be essential for bacterial viability have been largely  22 
unsuccessful (31). Unlike target-based assays, however, whole-organism screening has  23 Clatworthy et al. 
  27 
the potential to directly identify compounds that are effective at eliciting the desired  1 
phenotype (like attenuation of infection) and has the potential to leap-frog over some of  2 
the major hurdles associated with drug development in that whole organism screening  3 
inherently selects for compounds that are permeable to the cell, have little to no gross  4 
toxic side effects, and have acceptable pharmacokinetic profiles (at least in the model  5 
host) (24). While examples of whole organism screening for anti-infectives in rodent  6 
models are extremely rare due to space, cost, and even ethical considerations, they have  7 
historically resulted in the successful discovery of drugs like ivermectin, an anti-parasitic  8 
therapeutic (7). Recent efforts to conduct whole organism screening of invertebrate  9 
infection models have overcome many of the drawbacks associated with screening rodent  10 
infection models and have been successfully used to identified compounds effective at  11 
attenuating Enterococcus fecalis and Candida albicans infection in C. elegans (6, 28).  12 
The drawback to screening whole-organism invertebrate infection models, of course, is  13 
the relative dissimilarity between the invertebrate and mammalian immune response to  14 
infection. Since zebrafish are vertebrates with an immune system similar to mammals,  15 
whole organism screening of zebrafish infection models may be more effective at  16 
identifying compounds useful in treating human infections.  17 
We have demonstrated that zebrafish represent an effective new model for  18 
examining P. aeruginosa pathogenesis that has many advantages, including ease of  19 
manipulating the immune response in the setting of optical transparency. While  20 
visualizing and manipulating the immune response in rodent models are technically  21 
feasible using intravital microscopy and genetic tools, such studies will be technically  22 
easier, faster, and cheaper in zebrafish. Thus, zebrafish, as a model host, may provide a  23 Clatworthy et al. 
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unique forum in which to conduct comprehensive studies of pathogen mutants in the  1 
context of variations in host immunity and explore individual contributions of  2 
macrophage and neutrophil lineages to host defense. Given the ability to conduct both  3 
classical and chemical genetic studies, the ability to manipulate host immunity, and the  4 
ability to examine the infection as it progresses in the living organism, the zebrafish  5 
infection model is a useful complement to and combines the strengths of existing models  6 
of P. aeruginosa infection.  7 
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Figure Legends  1 
  2 
Fig. 1. P. aeruginosa infection in zebrafish embryos. A) Landmarks in the 28 hpf  3 
embryo; arrows indicate the direction of blood flow in the yolk circulation valley.  B)  4 
Kaplan-Meier embryo survival curves following infection of 28 hpf embryos with  5 
varying doses of PA14, heat-killed PA14, or E. coli DH5α; CFU, colony forming unit;  6 
HPI, hours post infection. Embryos were monitored for survival at 17 hpi and at regular  7 
intervals thereafter. The data are representative of 3 replicates with 30 embryos per  8 
condition per replicate. C) Kaplan-Meier embryo survival curves following infection of  9 
50 hpf embryos with varying doses of PA14 or heat-killed PA14. Embryos were  10 
monitored for survival at 20 hpi and at regular intervals thereafter. The data are  11 
representative of 3 replicates with 30 embryos per condition per replicate.   12 
  13 
Fig. 2. Visualization of P. aeruginosa PA14/GFP infection over time. Embryos staged 28  14 
hpf were infected with PA14/GFP (~1,800 CFU) or heat-killed bacteria and imaged over  15 
time (all scale bars, 200  m). A) Fluorescent image of an embryo infected with  16 
PA14/GFP at 4 hpi. B) Fluorescent image of the embryo in panel A at 22.5 hpi. C)  17 
Bright-field image of the embryo from panel A immediately after death, 24 hpi.  18 
Fluorescent (D) and brightfield (E) images of an embryo infected with heat-killed  19 
PA14/GFP at 22.5 hpi.   20 
  21 
Fig. 3. Expansion of P. aeruginosa in embryos over time. Bacterial enumeration from  22 
embryos infected 50 hpf with PA14/GFP (inoculum size ~10,200 CFU; each point  23 Clatworthy et al. 
  38 
represents CFU recovered from an individual embryo). From 6-48 hpi, each embryo was  1 
also scored for the presence of fluorescence (fluorescent (￿), non-fluorescent (￿)).  2 
  3 
Fig. 4.  Susceptibility to quorum sensing and T3S mutants is dependent on embryo  4 
developmental stage. A) Kaplan-Meier embryo survival curves following infection of 28  5 
hpf embryos with PA14 (~2300 CFU; N=30), PA14 pscD (~1800 CFU; N=30),  6 
PA14 mvfR (~2400 CFU; N=30), PA14 lasR (~1800 CFU; N=30), or heat-killed PA14  7 
(N=11). Embryos were monitored for survival at 17 hpi and at regular intervals  8 
thereafter; the data are representative of 3 replicates. B) Kaplan-Meier embryo survival  9 
curves following infection of 50 hpf embryos with PA14 (~8,000 CFU; N=32),  10 
PA14 lasR (~7,800 CFU; N=30), the PA14 lasR complemented strain (~6100 CFU;  11 
N=20), or heat-killed PA14 (N=12). C) Kaplan-Meier embryo survival curves following  12 
infection of 50 hpf embryos with PA14 (~6,300 CFU; N=30), PA14 mvfR (~5,900 CFU;  13 
N=30), the PA14 mvfR complemented strain (~8,100 CFU; N=20), or heat-killed PA14  14 
(N=10). D) Kaplan-Meier embryo survival curves following infection of 50 hpf embryos  15 
with PA14 (~5,000 CFU; N=30), PA14 pscD (~5,500 CFU; N=30), the PA14 pscD  16 
complemented strain (~6,300 CFU; N=30), or heat-killed PA14 (N=5). Embryos in  17 
panels B-D were monitored for survival at 20 hpi and at regular intervals thereafter; the  18 
data are representative of 3 replicates.  19 
  20 
Fig. 5. P. aeruginosa colocalizes with myeloid cells. A-D) DIC (A), Cy3-TSA (B), GFP- 21 
fluorescent (C), and merged (D) images of a neutrophil from an embryo inoculated 50  22 
hpf with ~4300 PA14/GFP bacterial cells that was fixed 1 hpi and stained for  23 Clatworthy et al. 
  39 
myeloperoxidase activity with Cy3-TSA. E-G) DIC (E), GFP-fluorescent (F), and  1 
merged (G) images of a macrophage obtained from a living embryo inoculated 50 hpf  2 
with ~8500 CFU PA14/GFP captured 3.75 hpi. All scale bars, 5  m.  3 
  4 
Fig 6.  Myeloid lineage cells control P. aeruginosa infection.  A) In situ hybridization for  5 
L-plastin expression, a marker for myeloid cells (20) in 24 hpf wildtype (top panel), Pu.1  6 
(middle panel) and Gata1 (bottom panel) morphants. B) Kaplan-Meier embryo survival  7 
curves following inoculation of 50 hpf PU.1 (PA14, ~5500 CFU;  pscD, ~6000 CFU) or  8 
control morphants (PA14, ~7000 CFU;  pscD, ~5000 CFU). C) Kaplan-Meier embryo  9 
survival curves following inoculation of 50 hpf GATA1 (PA14, ~6000 CFU;  pscD,  10 
~5900 CFU) or control morphants (PA14, ~6700 CFU;  pscD, ~4500 CFU).  The data  11 
are representative of 3 replicates with 30 embryos per condition per replicate.   12 
  13 
Fig 7.  Pro-inflammatory cytokine expression following P. aeruginosa infection.  14 
Relative TNFα (A) and IL-1β (B) transcript levels 4 and 18 hpi determined by qRT-PCR  15 
analysis in embryos that were infected either 28 hpf with ~2200 CFU or 50 hpf with  16 
~7000 CFU of either PA14,  lasR, heat-killed PA14, or DH5α cells. Fold changes in  17 
cytokine expression were determined relative to PBS-sham infected embryos. Data  18 
represent the mean and SEM of at least 3 biologic replicates.   19 
  20 
Fig. 8.  Antibiotics rescue embryos from lethal infection. A) Kaplan-Meier embryo  21 
survival curves following infection of 28 hpf embryos with PA14 and subsequent  22 
immersion in embryo medium containing either ciprofloxacin (150 g/ml; ~6500 CFU),  23 Clatworthy et al. 
  40 
imipenem (200 g/ml; ~6000 CFU), a combination of both antibiotics (150 g/ml  1 
ciprofloxacin; 200 g/ml imipenem; ~6600 CFU), or no antibiotic (~6700 CFU). Embryos  2 
were monitored for survival at 17 hpi and at regular intervals thereafter. The data are  3 
representative of 3 replicates with 30 embryos per condition per replicate. B) Kaplan- 4 
Meier embryo survival curves following infection of 50 hpf embryos with PA14 and  5 
subsequent immersion in embryo medium containing ciprofloxacin (50 g/ml; ~8400  6 
CFU), imipenem (50 g/ml; ~8500 CFU), or no antibiotic (~8200 CFU). Embryos were  7 
monitored for survival at 19 hpi and at regular intervals thereafter. The data are  8 
representative of 3 replicates with 30 embryos per condition per replicate.   9 
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